Back
Cyclacel Pharmaceuticals Vs. Anterix Industry Stock Comparison
Sell
12
CYCC
Cyclacel Pharmaceuticals
Last Price:
1.61
Seasonality Move:
-15.51%
Buy
71
ATEX
Anterix
Last Price:
39.41
Seasonality Move:
-0.81%
Sell
12
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy, Sell or Hold?
- The current Cyclacel Pharmaceuticals [CYCC] share price is $1.66. The Score for CYCC is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- CYCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Anterix (ATEX)
is a Buy
Is Anterix a Buy, Sell or Hold?
- The current Anterix [ATEX] share price is $39.18. The Score for ATEX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- ATEX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CYCC Stock Price Chart
What is Cyclacel Pharmaceuticals's stock price today?
-
The Cyclacel Pharmaceuticals share price today is $1.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYCC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATEX Stock Price Chart
CYCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 44.71 | Sell |
| Chaikin Money Flow: | 10061 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.6 - 2.1) | Sell |
| Bollinger Bands (100): | (1.79 - 2.55) | Sell |
ATEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.3 | Buy |
| Relative Strength Index (14 RSI): | 75.96 | Buy |
| Chaikin Money Flow: | 16341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.21 - 35.77) | Buy |
| Bollinger Bands (100): | (31.06 - 36.26) | Buy |
CYCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Sell |
| 20-day SMA: | 1.77 | Sell |
| 50-day SMA: | 2 | Sell |
| 200-day SMA: | 3.55 | Sell |
| 8-day EMA: | 1.68 | Sell |
| 20-day EMA: | 1.77 | Sell |
| 50-day EMA: | 1.96 | Sell |
| 200-day EMA: | 3.95 | Sell |
ATEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.52 | Buy |
| 20-day SMA: | 32.9 | Buy |
| 50-day SMA: | 32.61 | Buy |
| 200-day SMA: | 32.76 | Buy |
| 8-day EMA: | 35.89 | Buy |
| 20-day EMA: | 33.82 | Buy |
| 50-day EMA: | 33.09 | Buy |
| 200-day EMA: | 33.04 | Buy |
Cyclacel Pharmaceuticals Earnings Growth & CYCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.23 per share, and an increase next year of $0.61 per share.
Anterix Earnings Growth & ATEX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.71 per share, an increase this year of $3.17 per share, and a decrease next year of $2.65 per share.
Cyclacel Pharmaceuticals Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Anterix Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||